Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Clinical Implications of p53 Dysfunction in Patients with Myelodysplastic Syndromes

Blood (2022) 140 (Supplement 1): 4001–4004.

https://doi.org/10.1182/blood-2022-166050

Published: 2022

Journal Articles

Clinical relevance of clonal hematopoiesis in persons aged ≥80 years

Marianna Rossi, Manja Meggendorfer, Matteo Zampini, Mauro Tettamanti, Emma Riva, Erica Travaglino, Matteo Bersanelli, Sara Mandelli, Alessia Antonella Galbussera, Ettore Mosca, Elena Saba, Chiara Chiereghin, Nicla Manes, Chiara Milanesi, Marta Ubezio, Lucio Morabito, Clelia Peano, Giulia Soldà, Rosanna Asselta, Stefano Duga, Carlo Selmi, Maria De Santis, Karolina Malik, Giulia Maggioni, Marilena Bicchieri, Alessia Campagna, Cristina A. Tentori, Antonio Russo, Efrem Civilini, Paola Allavena, Rocco Piazza, Giovanni Corrao, Claudia Sala, Alberto Termanini, Laura Giordano, Paolo Detoma, Aurelio Malabaila, Luca Sala, Stefano Rosso, Roberto Zanetti, Claudia Saitta, Elena Riva, Gianluigi Condorelli, Francesco Passamonti, Armando Santoro, Francesc Sole, Uwe Platzbecker, Pierre Fenaux, Niccolò Bolli, Gastone Castellani, Wolfgang Kern, George S. Vassiliou, Torsten Haferlach, Ugo Lucca, Matteo G. Della Porta

Blood (2021) 138 (21): 2093–2105.

https://doi.org/10.1182/blood.2021011320

Published: 2021

Includes: Supplemental data

Journal Articles

Clinical Relevance of Clonal Hematopoiesis in the Oldest-Old Population: Analysis of the "Health and Anemia" Study

Blood (2018) 132 (Supplement 1): 750.

https://doi.org/10.1182/blood-2018-99-114717

Published: 2018

Journal Articles

Clinical Implications of TP53 Mutations and p53 Dysfunction in Patients with Myelodysplastic Syndrome (MDS). a Study from the Italian MDS Clinical Network

Blood (2017) 130 (Supplement 1): 2959.

https://doi.org/10.1182/blood.V130.Suppl_1.2959.2959

Published: 2017

Journal Articles

Driver Somatic Mutations and Transplantation Decision Making in Patients with Myelodysplastic Syndrome

Blood (2016) 128 (22): 53.

https://doi.org/10.1182/blood.V128.22.53.53

Published: 2016

Journal Articles

LNK mutations in familial myeloproliferative neoplasms

Elisa Rumi, Ashot S. Harutyunyan, Daniela Pietra, Jelena D. Milosevic Feenstra, Chiara Cavalloni, Elisa Roncoroni, Ilaria Casetti, Marta Bellini, Chiara Milanesi, Maria C. Renna, Manuel Gotti, Cesare Astori, Robert Kralovics, Mario Cazzola

Blood (2016) 128 (1): 144–145.

https://doi.org/10.1182/blood-2016-04-711150

Published: 2016

Journal Articles

Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms

Blood (2016) 127 (3): 325–332.

https://doi.org/10.1182/blood-2015-07-661835

Published: 2016

Includes: Supplemental data

Journal Articles

The Impact of Driver Mutations of JAK2, Calr , or MPL in Patients with Myelofibrosis Undergoing Hemopoietic Stem Cell Transplantation

Andrea Bacigalupo, MD, Sarah Pozzi, Maria Teresa van Lint, MD, Stefania Bregante, Gianni Barosi, Daniela Pietra, PhD, Elisa Rumi, MD, Chiara Milanesi, Mario Cazzola, MD

Blood (2015) 126 (23): 5405.

https://doi.org/10.1182/blood.V126.23.5405.5405

Published: 2015

Journal Articles

Mutation Type As a Major Determinant of Clinical Phenotype in Myeloproliferative Neoplasms Associated with Mutant Calreticulin

Daniela Pietra, PhD, Elisa Rumi, MD, Chiara Milanesi, BS, Christian A Di Buduo, PhD, Marta Bellini, MD, Ilaria Carola Casetti, MD, Chiara Cavalloni, MD, Emanuela Sant'Antonio, Vittorio Abbonante, PhD, Maria C Renna, BS, Virginia Ferretti, PhD, Emanuela Boveri, MD, Alessandra Balduini, MD, Cristiana Pascutto, PhD, Mario Cazzola, MD

Blood (2014) 124 (21): 3215.

https://doi.org/10.1182/blood.V124.21.3215.3215

Published: 2014

Journal Articles

Clinical effect of driver mutations of JAK2 , CALR , or MPL in primary myelofibrosis

Blood (2014) 124 (7): 1062–1069.

https://doi.org/10.1182/blood-2014-05-578435

Published: 2014

Journal Articles

CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis

Elisa Rumi, Ashot S. Harutyunyan, Daniela Pietra, Jelena D. Milosevic, Ilaria C. Casetti, Marta Bellini, Nicole C. C. Them, Chiara Cavalloni, Virginia V. Ferretti, Chiara Milanesi, Tiina Berg, Emanuela Sant’Antonio, Emanuela Boveri, Cristiana Pascutto, Cesare Astori, Robert Kralovics, Mario Cazzola

Blood (2014) 123 (15): 2416–2419.

https://doi.org/10.1182/blood-2014-01-550434

Published: 2014

Includes: Supplemental data

Journal Articles

JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes

Blood (2014) 123 (10): 1544–1551.

https://doi.org/10.1182/blood-2013-11-539098

Published: 2014

Includes: Supplemental data

Journal Articles

Frequent Mutations in the Calreticulin Gene CALR in Myeloproliferative Neoplasms

Blood (2013) 122 (21): LBA-1.

https://doi.org/10.1182/blood.V122.21.LBA-1.LBA-1

Published: 2013

Journal Articles

JAK2 (V617F)-Positive Essential Thrombocythemia and Polycythemia Vera Are Different Expressions Of a Genotypic/Phenotypic Continuum

Elisa Rumi, MD, Daniela Pietra, PhD, Chiara Elena, MD, Ilaria Casetti, MD, Emanuela Sant 'Antonio, MD, Cesare Astori, MD, Chiara Milanesi, PhD, Marta Bellini, MD, Emanuela Boveri, MD, Virginia Ferretti, DR, Cristiana Pascutto, PhD, Mario Cazzola, MD

Blood (2013) 122 (21): 1592.

https://doi.org/10.1182/blood.V122.21.1592.1592

Published: 2013

Journal Articles

Acquired copy-neutral loss of heterozygosity of chromosome 1p as a molecular event associated with marrow fibrosis in MPL -mutated myeloproliferative neoplasms

Blood (2013) 121 (21): 4388–4395.

https://doi.org/10.1182/blood-2013-02-486050

Published: 2013

Includes: Supplemental data

Journal Articles

Clonal Analysis of SF3B1 , JAK2 and MPL in Refractory Anemia with Ring Sideroblasts Associated with Marked Thrombocytosis

Ilaria Ambaglio, Anna Gallì, Daniela Pietra, Matteo G Della Porta, Marta Ubezio, Matteo C Da Vià, Elisa Bono, Chiara Milanesi, Erica Travaglino, Rosangela Invernizzi, Elli Papaemmanuil, Peter Campbell, Luca Malcovati, Mario Cazzola

Blood (2012) 120 (21): 172.

https://doi.org/10.1182/blood.V120.21.172.172

Published: 2012

NARROW

Clinical Implications of p53 Dysfunction in Patients with Myelodysplastic Syndromes

Clinical relevance of clonal hematopoiesis in persons aged ≥80 years

Clinical Relevance of Clonal Hematopoiesis in the Oldest-Old Population: Analysis of the "Health and Anemia" Study

Clinical Implications of TP53 Mutations and p53 Dysfunction in Patients with Myelodysplastic Syndrome (MDS). a Study from the Italian MDS Clinical Network

Driver Somatic Mutations and Transplantation Decision Making in Patients with Myelodysplastic Syndrome

LNK mutations in familial myeloproliferative neoplasms

Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms

The Impact of Driver Mutations of JAK2, Calr , or MPL in Patients with Myelofibrosis Undergoing Hemopoietic Stem Cell Transplantation

Mutation Type As a Major Determinant of Clinical Phenotype in Myeloproliferative Neoplasms Associated with Mutant Calreticulin

Clinical effect of driver mutations of JAK2 , CALR , or MPL in primary myelofibrosis

CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis

JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes

Frequent Mutations in the Calreticulin Gene CALR in Myeloproliferative Neoplasms

JAK2 (V617F)-Positive Essential Thrombocythemia and Polycythemia Vera Are Different Expressions Of a Genotypic/Phenotypic Continuum

Acquired copy-neutral loss of heterozygosity of chromosome 1p as a molecular event associated with marrow fibrosis in MPL -mutated myeloproliferative neoplasms

Clonal Analysis of SF3B1 , JAK2 and MPL in Refractory Anemia with Ring Sideroblasts Associated with Marked Thrombocytosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only